Selective serotonin reuptake inhibitors affect structure, function and metabolism of skeletal muscle: A systematic review

被引:10
|
作者
Visco, Diego Bulcao [1 ]
Manhaes-de-Castro, Raul [2 ]
Chaves, Wenicios Ferreira [1 ]
Lacerda, Diego Cabral [1 ]
Pereira, Sabrina da Conceicao [3 ]
Ferraz-Pereira, Kelli Nogueira [4 ]
Toscano, Ana Elisa [5 ]
机构
[1] Univ Fed Pernambuco, Postgrad Program Nutr, Recife, PE, Brazil
[2] Univ Fed Pernambuco, Dept Nutr, Recife, PE, Brazil
[3] Univ Fed Pernambuco, Postgrad Program Phys Therapy, Recife, PE, Brazil
[4] Univ Fed Pernambuco, CAV, Dept Phys Educ & Sports Sci, Vitoria De Santo Antao, PE, Brazil
[5] Univ Fed Pernambuco, CAV, Dept Nursing, Rua Alto Reservatorio S-N, BR-55608680 Vitoria De Santo Antao, PE, Brazil
关键词
Serotonin uptake inhibitors; Serotonin; Skeletal muscle; Systematic review; CONGENITAL MYASTHENIC SYNDROME; CUTANEOUS SILENT PERIOD; FLUOXETINE TREATMENT; MYOTONIC-DYSTROPHY; GLUCOSE-METABOLISM; INSULIN-RESISTANCE; NEONATAL TREATMENT; DIABETES-MELLITUS; RAT; ANTIDEPRESSANTS;
D O I
10.1016/j.phrs.2018.09.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Selective Serotonin Reuptake Inhibitors (SSRIs) may have side effects, such as stiffness, tremors and altered tonic activity, as well as an increased risk of developing insulin resistance and diabetes mellitus. However, little is known about the structural, functional and metabolic changes of skeletal muscle after administration of SSRIs. The aim of this systematic review was to explore and discuss the effects of SSRIs on skeletal muscle properties described in human and rodent studies. A systematic search of PUBMED, SCOPUS, and WEB OF SCIENCE was performed. The inclusion criteria were intervention studies in humans and rodents that analysed the effects of SSRIs on skeletal muscle properties. The research found a total of six human studies, including two randomized controlled trials, one non-randomized controlled trial, one uncontrolled before-after study and two case reports, and six preclinical studies in rodents. Overall, the studies in humans and rodents showed altered electrical activity in skeletal muscle function, assessed through electromyography (EMG) and needle EMG in response to chronic treatment or local injection with SSRIs. In addition, rodent studies reported that SSRIs may exert effects on muscle weight, the number of myocytes and the cross-sectional area of skeletal muscle fibre. The results showed effects in energy metabolism associated with chronic SSRI use, reporting altered levels of glycogen synthase activity, acetyl-CoA carboxylase phosphorylation, citrate synthase activity, and protein kinase B Ser phosphorylation. Moreover, changes in insulin signalling and glucose uptake were documented. In this context, we concluded based on human and rodent studies that SSRIs affect electrical muscle activity, structural properties and energy metabolism in skeletal muscle tissue. However, these changes varied according to pre-existing metabolic and functional conditions in the rodents and humans.
引用
收藏
页码:194 / 204
页数:11
相关论文
共 50 条
  • [21] Use of selective serotonin reuptake inhibitors and risk of stroke: a systematic review and meta-analysis
    Shin, Doosup
    Oh, Yun Hwan
    Eom, Chun-Sick
    Park, Sang Min
    JOURNAL OF NEUROLOGY, 2014, 261 (04) : 686 - 695
  • [22] Use of selective serotonin reuptake inhibitors and risk of fracture: A systematic review and meta-analysis
    Eom, Chun-Sick
    Lee, Hyun-Ki
    Ye, Sungmin
    Park, Sang Min
    Cho, Kyung-Hwan
    JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (05) : 1186 - 1195
  • [23] Selective serotonin reuptake inhibitors in major depression disorder treatment: an umbrella review on systematic reviews
    Darab, Mohsen Ghaffari
    Hedayati, Arvin
    Khorasani, Elahe
    Bayati, Mohsen
    Keshavarz, Khosro
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2020, 24 (04) : 357 - 370
  • [24] Great boast, small roast on effects of selective serotonin reuptake inhibitors: response to a critique of our systematic review
    Katakam, Kiran Kumar
    Sethi, Naqash Javaid
    Jakobsen, Janus Christian
    Gluud, Christian
    ACTA NEUROPSYCHIATRICA, 2018, 30 (05): : 251 - 265
  • [25] Use of selective serotonin reuptake inhibitors and risk of stroke: a systematic review and meta-analysis
    Doosup Shin
    Yun Hwan Oh
    Chun-Sick Eom
    Sang Min Park
    Journal of Neurology, 2014, 261 : 686 - 695
  • [26] Do selective serotonin reuptake inhibitors acutely increase frontal cortex levels of serotonin?
    Beyer, Chad E.
    Cremers, Thomas I. F. H.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 580 (03) : 350 - 354
  • [27] The pharmacogenomics of selective serotonin reuptake inhibitors
    Garcia-Marin, Luis M.
    Rabinowitz, Jill A.
    Ceja, Zuriel
    Alcauter, Sarael
    Medina-Rivera, Alejandra
    Renteria, Miguel E.
    PHARMACOGENOMICS, 2022, 23 (10) : 597 - 607
  • [28] The effects of selective serotonin reuptake inhibitors on memory functioning in older adults: A systematic literature review
    Schulkens, Julie E. M.
    Deckers, Kay
    Jenniskens, Maud
    Blokland, Arjan
    Verhey, Frans R. J.
    Sobczak, Sjacko
    JOURNAL OF PSYCHOPHARMACOLOGY, 2022, 36 (05) : 578 - 593
  • [29] Systematic review with meta-analysis: selective serotonin reuptake inhibitors for noncardiac chest pain
    Atluri, D. K.
    Chandar, A. K.
    Fass, R.
    Falck-Ytter, Y.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (02) : 167 - 176
  • [30] Selective serotonin reuptake inhibitors and acne
    Daveluy, Amelie
    de Bazignan, Adelaiede Doussait
    Thiessard, Frantz
    Miremont-Salame, Ghada
    Moore, Nicholas
    Haramburu, Francoise
    THERAPIE, 2006, 61 (01): : 71 - 72